Slope-Assisted Brillouin Optical Time Domain Analysis (SA-BOTDA) is a fast and distributed sensing technique that interrogates the Brillouin gain spectrum (BGS) near the middle of the linear region of its slope, allowing the measurement of high frequency vibrations. However, environmentally-induced deviations of the interrogation point from the rather small linear region around the optimum frequency position, result in harmonic distortion and changes in the slope value, which determines the gain-to-frequency conversion factor. Engineering the BGS by adding a loss probe, we propose a novel and improved version of SA-BOTDA, having a significantly wider drift tolerance for the interrogation point. Here, using a 14 ns pump pulse and a judicious choice of the frequency of the loss probe, we demonstrate an engineered BGS having a 70% wider frequency range (as compared with the conventional BGS), where the interrogation point can drift without compromising either the prescribed level of harmonic distortion or the given slope tolerance, further benefiting the flexibility and usage of SA-BOTDA.
Numerical solution of the involved governing equations confirm that the commonly used two orthogonal sets of gain- and loss-probes in BOTDA, differently affect the evolution of the pump state-of- polarization, thereby potentially compromising the minimization of polarization fading.
Accurate simulations of Tailored-Probe slope-assisted BOTDA may require the use of a higher-order equation for the acoustic field, especially for large variations of the fiber BFS. Successful application of this approach to various scenarios is demonstrated.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.